These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 15986012)
1. Novel combinations in the treatment of hypertension. Sica DA Minerva Urol Nefrol; 2005 Sep; 57(3):129-39. PubMed ID: 15986012 [TBL] [Abstract][Full Text] [Related]
2. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
3. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy in hypertension. Gorostidi M; de la Sierra A Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510 [TBL] [Abstract][Full Text] [Related]
7. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens. Moser M Am J Cardiol; 1989 Jan; 63(4):2B-7B. PubMed ID: 2563187 [TBL] [Abstract][Full Text] [Related]
8. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Reboldi G; Gentile G; Angeli F; Verdecchia P Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778 [TBL] [Abstract][Full Text] [Related]
9. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker. Kuti EL; Baker WL; White CM Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720 [TBL] [Abstract][Full Text] [Related]
11. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment? Brown A; Captain B Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766 [TBL] [Abstract][Full Text] [Related]
13. Update on the management of hypertension: do recent clinical trial results indicate a change in national recommendations for therapy? Moser M J Clin Hypertens (Greenwich); 2002; 4(6 Suppl 2):20-31. PubMed ID: 12461317 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis. Palmas W; Ma S; Psaty B; Goff DC; Darwin C; Barr RG Am J Hypertens; 2007 Mar; 20(3):233-41. PubMed ID: 17324732 [TBL] [Abstract][Full Text] [Related]
15. Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker? Riva N; Lip GY Curr Pharm Des; 2013; 19(21):3753-65. PubMed ID: 23286431 [TBL] [Abstract][Full Text] [Related]
16. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner. Roberts ME; Epstein BJ J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098 [TBL] [Abstract][Full Text] [Related]
18. Selecting antihypertensive medication in patients with essential hypertension in Malaysia. Ong HT; Rozina G Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313 [No Abstract] [Full Text] [Related]
19. [Intervention studies on elderly hypertensive patients in Japan]. Saito F; Takahashi A; Kushiro T Nihon Rinsho; 2005 Jun; 63(6):1078-85. PubMed ID: 15948394 [TBL] [Abstract][Full Text] [Related]
20. [Management of hypertension in upheaval?]. Zidek W; Paul M Dtsch Med Wochenschr; 2005 Nov; 130(46):2627. PubMed ID: 16281156 [No Abstract] [Full Text] [Related] [Next] [New Search]